Thank you for your submission. The information will be live within the next 24-48 hours.
AstraZeneca - ADDC Collaboration
The collaboration allows for ADDC members to have direct access to the AstraZeneca's library of compounds.
This collaboration between ADDC and AstraZeneca is aimed at at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application.
Click here for more information
Highlighted Partnerships
CDRD |
Share resources for the discovery of new drugs stemming rom CDRD and IPS. |
Creative BioMart |
|
|
CEO |
development of peptide therapeutics to metastatic cancer |
The Division of Signal Transduction Therapy |
| A vital asset of the MRC-PPU is the Division of Signal Transduction Therapy (DSTT) which was established in 1998. This division operates as a unique collaboration between scientists in the MRC-PPU (all PIs... |
Argenta and ANTABIO Announce Drug Discovery Collaboration |
| Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration pa... |
Therapeuitic Areas of Expertise
-
ChoicesPercentage
-
Oncology29.79%
-
Infectious Diseases12.77%
-
Neurological Disorders31.91%
-
Immunology23.4%
-
Metabolic Disorders21.28%
-
Cardiology12.77%
-
Pain6.38%
-
Other12.77%
-
Therapeutic Approaches
-
ChoicesPercentage
-
Small Molecules76.6%
-
Biologics38.3%
-
Biomarkers2.13%
-
Drug Delivery2.13%
-
Stem Cells2.13%
-
Vaccines0%
-
Antibodies8.51%
-
Other2.13%
-